Tag: pharmaceutical
-
Armata Pharmaceuticals Gets $7.0M Investment
Marina Del Rey-based Armata Pharamceuticals, a biotechnology company developing therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, said it has received $3.0M in an equity investment from the Cystic Fibrosis Foundation (C…
-
Cellibre Snags $11.5M For Cannabis Biotech Effort
San Diego-based Cellibre, which says it is developing ways to produce cannabinoids using pharmaceutical cell lines rather than traditional agriculture, has raised $11.5M in a Series A funding. The company said the funding was led by Merida Capital Hold…
-
RayzeBio Snags $108M for Cancer Drug Efforts
San Diego-based RayzeBio, a pharmaceuticals company which says it is developing targeted radiopharmaceutical drugs for cancer, has raised $108M in its Series C funding. The company said it has now raised a total of $258M. The new funding was led by Ve…
-
Onchilles Pharma Finds $7M For Cancer Drugs
San Diego-based Onchilles Pharma said this morning that it has raised $7M in a Series A funding round. The funding came from LYZZ Capital, and also included $500K from the University of Chicago’s Startup Investment Fund. According to the company, it is…
-
ImaginAB Gets $12.8M
Los Angeles-based ImaginAb, a biotechnology company which is developing radiopharmaceutical imaging and therapy agents, has raised $12.8M in a funding round, the company said on Thursday. According to the company, the funding was led by Adage Capital a…
-
Phanes Therapeutics Lands $40M
San Diego-based Phanes Therapeutics, a developer of immuno-oncology drugs, has raised $40M in its Series B funding round. The funding was led by Sequoia Capital China, and also included the company other investors. Names of the other investors were not…
-
Narrativa Raises $1.3M
Los Angeles-based Narrativa, a developer of artificial intelligence software aimed at helping pharmaceutical companies with FDA drug approvals, says it has raised $1.3M in a financing round. Source of the new funding was not announced. According to Nar…